The transfer factor, TL,CO (with the transfer coefficient, KCO, also known as the transfer factor per unit alveolar volume, [TL/VA]), is one of the most useful clinical tests of pulmonary function, the only one which specifically focuses on pulmonary microcirculation. It was originally devised in 1909 as a physiological tool to assess the diffusive capacity of the lung as a gas exchanger. It was subsequently developed as a clinical tool, but cumbersome analytical techniques delayed its introduction into clinical medicine until 1950s. The physiology of the carbon monoxide transfer factor (also called the diffusing capacity DL,CO) is based on the Roughton-Forster equation which partitions DL,CO, a conductance, into membrane (DM) and red cell (hVC) diffusion conductances. Recent work (1987)(1988)(1989)(1990)(1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001) suggests that 70-80% of the resistance to CO (and O 2 ) diffusion may reside in the red cell fraction. The clinical implication is that TL,CO and KCO are 'windows' onto the pulmonary microcirculation. As regards reference values for clinical use, TL,CO depends on age, height and gender. KCO, which is actually a rate constant, is independent of gender, and is affected principally by age. A schema is presented for the clinical interpretation of TL,CO. As TL,CO is derived from the product of KCO and the accessible alveolar volume (VA), examination of these two components (KCO and VA) will usually suggest a specific pathophysiological mechanism as the explanation for a reduction in TL,CO.
Introduction
The transfer factor of the lung for carbon monoxide (TL,CO), also known as the diffusing capacity (DL,CO), has become one of the key tests of pulmonary function. TL,CO measures the potential of the lung for gas exchange. For example, a patient with interstitial lung disease might have a low TL,CO (DL,CO), (say <50% predicted normal), but could still have a normal arterial PO 2 (PaO 2 ) at rest; but on exercise, PaO 2 will fall, often severely, because the lung has insufficient gas exchanging surface area to meet the additional oxygen demand. As will be seen later, the particular surface area which is crucial is that of the microvascular bed, in particular the number of capillaries.
for which DL,CO was after all only a substitute. It could be argued that this paper ushered in a new era in gas exchange research. The ingenuity of Lilienthal's method lay in the differentiation of end-capillary (Pc'O 2 ) from arterial (PaO 2 ) oxygen tension; this was achieved by measuring alveolar and arterial PO 2 on exercise breathing air, followed by a 10-12% O 2 hypoxic mixture. They were delighted when the steady state DLO 2 values were similar to Krogh's (1915) single breath DL,CO measurements, also made on exercise.
Steady state DL,CO
With the revival of interest in diffusion measurements, several groups (Bates, 1952; Filley et al., 1954; Bates et al., 1955) thought it more appropriate to measure DL,CO by a steady state technique (DL,CO ss), similar to that for DLO 2 . The measurement of DL,CO ss was a much easier proposition than DLO 2 . There was no need to repeat the measurement under hypoxic conditions, P c c (the mean capillary tension) for CO could be ignored (haemoglobin being considered an infinite sink for CO), and DL,CO ss computed as _ V VCO/PACO, where _ V VCO is CO uptake in ml min
, and PA is the alveolar tension. [note: DLO 2 ¼ ( _ V VO 2 ⁄ (PAO 2 -P c cO 2 )]. The measurement of DL,CO ss was straightforward, but the assessment of PACO by direct sampling was problematic in the presence of a sloping alveolar plateau of CO concentration on expiration, as was frequently the case in respiratory disease. The solution of Filley et al. (1954) was to calculate an 'ideal' PACO, as for the alveolar-arterial gradient for oxygen, although this involved taking an arterial sample for PaCO 2 . A few simultaneous comparisons, mostly in normal subjects, were made on exercise of DL,CO ss and DLO 2 and there was reasonable concordance (Forster et al., 1955; Shepard et al., 1958) . DL,CO sb exceeded DL,CO ss at rest by about 33% (Marshall, 1958) , but the two measurements converged on exercise.
Steady state or single breath DL,CO?
In the late 1950s, Ogilvie et al. (1957) published their 'standardized technique' for the single breath DL,CO, called DL,CO sb, incorporating Fowler's helium modification (Forster et al. (1954a) ; see earlier]. In the 1960s, DL,CO ss or DL,CO sb were being introduced in the pulmonary function laboratories of most University Departments. By the 1970s, the concept and clinical usefulness of DL,CO (now called TL,CO throughout Europe) was widely accepted and it was the single breath technique which became the method of choice. The reasons were pragmatic. DL,CO sb did not require an arterial sample, nor meticulous timing of alveolar samples. It was more acceptable to patients and staff. In 1965, an automated apparatus for measuring DL,CO sb came onto the market (Meade et al., 1965) . It was a success and other manufacturers followed suit. Once DL,CO became a 'black box' test, any inhibitions clinicians might have had about setting it up were quickly dispelled!
Physiology of DL,CO (TL,CO)
The Kroghs believed that CO uptake from alveolar gas occurred by passive diffusion across the alveolar-capillary membranes, driven by the PA-P c c gradient for CO. Krogh & Krogh (1909) converted DL,CO to DL,O 2 by multiplying by 1.23 which is the ratio of the tissue diffusivities of O 2 and CO. Following Christian Bohr (1909) who was August Krogh's teacher, they reasoned that P c cCO would be negligible because of the high affinity of CO for Hb. As we have seen, this assumption greatly simplifies the measurement. Like many assumptions, it proved to be only partially correct (see later)! Nevertheless, until the 1940s, resistance to gas exchange was considered to be 'diffusive', i.e. proportional to the thickness/ surface area ratio of the intervening membranes and tissues. For pulmonary gas exchange, the final step for oxygen, the combination with haemoglobin to form HbO 2 , was thought to be practically instantaneous (just a few milliseconds). Roughton (1932) , on the other hand, [from his work with Hartridge (Hartridge & Roughton, 1923) ], noted that the reaction velocity for O 2 or CO was seven to 10 times slower in intact red cells than in haemoglobin solutions, and he concluded that diffusion resistance of the red cell membrane and the interior of the cell was responsible.
In the 1950s, R.E. Forster was asked by Julius Comroe (Head of Physiology at the University of Pennsylvania) to repeat Krogh's (1915) measurements with the aim of developing a clinically useful test (Comroe, 1975) . Forster became (fortunately for us!) sidetracked by his desire to understand exactly what was being measured by DL,CO (Forster et al., 1954b) . His research, with several collaborators including Roughton (a frequent visitor to Philadelphia from his laboratory in Cambridge), culminated in the publication of a famous article (Roughton & Forster, 1957) containing the equation: Figure 1 Concentrations of the test gases (carbon monoxide and helium) plotted against breath hold time for the single breath TL,CO manoeuvre illustrating the origin and calculation of the two components (KCO and VA) from which the TL,CO is derived. VA ¼ alveolar volume at which the KCO was measured.
where DM is the diffusing capacity of the membranes separating the alveolar gas from the red cell itself; h is the rate of reaction of CO with red cells (sometimes called the diffusing capacity per ml of blood), and VC is the microvascular (capillary) blood volume in contact with the inhaled CO. Kruhoffer (1954) Roughton & Forster (1957) also showed, from measurements of DL,CO at two or more alveolar PO 2 levels (ideally 150-200 and 500-600 mmHg) and knowing hCO at the appropriate PAO 2 , that DM and VC could be calculated by a simple graphical method.
The membrane diffusing capacity
The DM is determined by the tissue diffusivity [solubility/ (mol. wt) )2 ] of O 2 or CO in lung tissue and the surface area/ thickness ratio of the epithelial, interstitial, endothelial and plasma barriers. In physiological terms, DM is a function of the expansion of the lung. With a doubling of the gas volume of the lung (from 50 to 100% TLC) DM increases by about 75%, but DL,CO by only 25% (VC does not change) (Stam et al., 1991) . Increases of DM as the lung expands are caused by a mixture of airspace spherical expansion and unfolding of the surface. Unfortunately, the measurement of DM is not independent of VC, because intracapillary Hb must be present for DM to be detected. Also, changes in the dimensions of the VC component will alter DM.
The diffusing capacity of blood
In vivo, hCO is inversely proportional to PO 2 . The original in vitro measurements of Roughton & Forster (1957) were carried out at pH 7.8-8.0. More recent estimates (Forster, 1987) at physiological pH have resulted in significantly lower 1/h values at high PO 2 s. If, in the Roughton-Forster equation, the 1987 1/h are substituted for the 1957 ones, DM increases 2.5-3.5 times, and VC decreases by 33% . Nearly all published DM and VC values have used the 1957 hCO values, a notable exception being Borland & Cox (1991) and Borland et al. (2001) .
Pulmonary capillary volume
As measured by the Roughton-Forster technique, capillary volumes (with 1957 1/h ) are in the range 80-100 ml (females) and 100-120 ml (males) at rest, and 125-210 ml (males and females) on exercise (Hsia et al., 1995) . These values would be about 33% lower if the 1987 1/h were to be used. Morphometric values for VC at rest, from post-mortem lungs, are about 200 ml (ranging from 120-280 ml depending on body weight) (Gehr et al., 1978) . Because of the Fa˚hreus-Lindqvist effect, whereby red cells accelerate relative to mean plasma flow in their passage through the capillary bed, capillary haematocrit (Hct ) is less than that in larger vessels. In fact, pulmonary capillary Hct is about 67% of large vessel Hct (Brudin et al., 1986) . This effect does not change VC estimates because there is an equal and opposite reduction in hCO.
Diffusing capacity for nitric oxide
In the last 15 years, the alveolar uptake of nitric oxide (NO) has been studied (Guenard et al., 1987; Borland & Higenbottam, 1989) . The theory and technique for estimating DL,NO is identical to that for DL,CO. DL,NO is four to five times greater than DL,CO. The reason is that hNO is nearly seven times larger than hCO (Carlsen & Comroe, 1958) . From simultaneous inhalation of NO and CO, DL,NO and DL,CO can be calculated, and the Roughton-Forster equation solved on the basis of two values of 1/h (1/hNO and 1/hCO), instead of two values of 1/hCO at different PAO 2 s (Borland & Cox, 1991; Borland et al., 2001) . This has the effect of increasing DM,CO by three to four times, and reducing the VC/DM ratio from about 2 to 0.35.
Red cell resistance fraction
As mentioned earlier, the general view, before the Roughton & Forster (1957) paper, was that DL,CO$DM with no resistance to diffusion attributable to the reaction of CO with haemoglobin. When DL,CO was partitioned into DM and VC using the original 1957 hCO values, the red cell resistance fraction varied from 32-56% (Forster, 1957) . With the morphometric analysis, the red cell resistance fraction is in the range 50-80% (Gehr et al., 1978) . Using the 1987 hCO values and Borland & Cox (1991) and Borland et al.'s (2001) hNO-hCO technique, this fraction has risen to 80%, i.e. most of the diffusion resistance is intracapillary. Thus, DL,CO measurements may be heavily weighted towards the numbers of red cells and/ or the number of capillary vessels. This new perception supports the views of clinicians who have maintained that DL,CO is a 'window on the pulmonary microcirculation'. Striking changes in DL,CO in severe anaemia (fl) [Rankin et al., 1961] , on exercise (›) [Hsia et al., 1995] , in intrapulmonary haemorrhage (›) [Ewan et al., 1976] , and in pulmonary vasculitis (fl) emphasize the pre-eminent role of the capillary bed. The ratio DL,O 2 /DL,CO in hypoxia is about 1.2 (Meyer et al., 1981) , the same as predicted (but for normoxia) by Krogh and Krogh in 1909 . If the DL,CO is measured in normoxia, the DL,O 2 / DL,CO ratio is 1.7, reflecting a combination of O 2 /CO ratios for DM (1.23) and h [c. 2.0; Forster, 1987) . Perhaps surprisingly, partitioning the DL,CO into its DM and VC components (not difficult to do even in patients) has not proved useful clinically. There are two reasons: first, DL,CO is dominated by its hVC component, and secondly, DM and VC measurements are coupled in the sense that VC must exist for DM to be measurable. The only examples of 'uncoupling' are congestive heart failure (Puri et al., 1995) (DM is reduced when VC is normal or high) and intrapulmonary haemorrhage (Ewan et al., 1976) (VC high, DM normal or reduced).
Clinical interpretation of TL,CO and KCO
Marie Krogh (1915) pointed out that the single breath TL,CO was the product of two separate measurements -the rate constant for CO removal from alveolar gas (which she called kCO) and the alveolar volume (VA). This simple concept is the key, in our opinion (Hughes & Pride, 2001) , to its clinical interpretation. kCO is measured as the exponential decay in fractional concentration of CO over a period of breath-holding (BHT) -see Fig. 1 :
where CO 0 and CO t are the alveolar CO concentrations at the start and finish of BHT. The units of kCO are s )1 or min )1 .
The total CO transfer of the lungs is calculated as:
where PB and PH 2 O are the barometric pressure and the water vapour pressure (at 37°C) which standardize for the driving pressure for CO uptake, i.e. the pressure of CO in the alveoli (PACO). The units of TL,CO are mmol min )1 kPa )1 (SI) and ml
In the original clinical description (Ogilvie et al., 1957) , and until 1965 when automated apparatus (and calculations) were introduced (Meade et al., 1965) , TLC was calculated independently from closed-circuit inert gas dilution (or body plethysmography) and used as 'VA'. In the absence of airflow obstruction, VA and TLC are approximately the same, but single breath VA may be considerably less than TLC when gas mixing is slow as in airflow obstruction (see later). Nowadays, the simultaneously measured single breath VA has replaced a separate measurement of TLC for logistic reasons; clinicians request TL,CO more frequently than TLC.
It is our contention that the logical way to interpret TL,CO, in the clinical context, is in terms of its components (VA and kCO) from which it is derived. Unfortunately, the simplicity of this approach has been obscured by modern nomenclature. Today, Krogh's kCO is deployed in different units (although it is the same rate constant) as the carbon monoxide transfer coefficient (KCO), whose units of mmol min 
Reference values
M. Krogh (1915) found that DL,CO was greater in men than in women, and Ogilvie et al. (1957) described the dependence of DL,CO on body surface area. Modern reference equations for TL,CO have height and age as coefficients, with separate regressions for men and women. The regression on height is determined by the VA component of TL,CO (VA in normal subjects being a surrogate for TLC). The regression on age is largely determined by the kCO component. Cotes & Hall (1970) pointed out that in young adults KCO was the same in both sexes, but declined with age at a faster rate in men than in women. For a man and a woman who started with the same KCO at age 25 years (say 1.8 in SI units), the male KCO at age 65 years would be 16% less than the woman's (from Cotes & Hall, 1970) . Population studies of KCO, which have included both men and women, show a dependence on age with the coefficient being significantly slightly greater in men (-0.023 years )1 in males versus -0.016 years )1 in females) (Hughes & Pride, in preparation) . Most of the studies showed, in addition, a dependence on height, although there is no logical reason why a rate constant, which is what KCO ($TL/VA) actually represents, should be dependent on stature or gender. The dependence on height is intriguing. Gulsvik et al. (1992) have made the interesting suggestion that, in the seated position, and in taller people, the apices of the lungs may be more poorly perfused relative to the mid and lower zones for gravitational reasons; the resulting inhomogeneity in blood flow and blood volume would reduce the measured KCO for taller people. In a review of the literature, we have found no significant gender difference for KCO at age 45 years, although a small (non-significant) difference emerges at age 65 years. The current EEC recommendations (Cotes et al., 1993) for reference values for KCO ($TL/VA) are based on [TL,CO(predicted) / TLC (predicted)]. The use of separate predictors, each with individual gender, height and (plus age for the TL,CO) coefficients, for the KCO, which is actually a rate constant, seems illogical. Further investigation seems to be required. 
Interpretation of TL,CO and KCO in lung disease
From eqn (3), TL,CO ¼ kCO · VA. Therefore, a low TL,CO must be caused by a low KCO or a low VA or a combination of the two. It is also possible for KCO to be high (as a percentage of that expected at the predicted TLC). As a mechanical analogy, note that FEV 1 ¼ FEV 1 /VC · VC, and the explanation for a low FEV 1 must be either a low FEV 1 /VC or a low VC or a combination (like KCO, FEV 1 /VC may be high). Note that the single breath TL,CO is performed at full inflation, close to TLC, in the seated position, and at rest. In the absence of airflow obstruction with impaired gas mixing, the single breath estimate of VA should approach that of TLC minus the anatomic dead space (about 200 ml). In practice, VA is about 94 ± 7% of TLC, 0.1-0.6 L less in absolute terms (Roberts et al., 1990) . In airflow obstruction the single breath VA may be considerably less than the true TLC measured by multi-breath gas dilution or body plethysmography (Roberts et al., 1990 ).
Causes of a low KCO
The common causes of a low KCO are well known -particularly emphysema and diffuse alveolar-capillary damage associated with connective tissue/ autoimmune disease (see Table 1 ). In the earlier section 'Physiology of DL,CO', we emphasized that most of the resistance to CO uptake lay within the microvasculature. Consequently, in lung disease, loss or destruction of the pulmonary capillary bed is a much more important mechanism for reducing KCO than thickening or inflammatory change in the extravascular tissues. In the Churg-Strauss syndrome and in bronchiolitis (Table 1 ) a low KCO suggests vasculitis (the pulmonary arterioles and bronchioles share a common connective tissue sheath). In addition, a physiological cause of a low KCO is a reduced haemoglobin level, and it is customary to make a correction for this (American Thoracic Society, 1995; Cotes et al., 1972 Cotes et al., , 1993 .
Causes of a high KCO
This is a more difficult concept to grasp. There are physiological reasons for a high KCO (in terms of percentage predicted for a normal TLC): first, incomplete alveolar expansion (but without alveolar disruption) in which the lungs are not inflated to the level of the predicted TLC, secondly, an increase in pulmonary blood flow per unit lung volume. KCO, in terms of the RoughtonForster equation, consists of two conductances, DM/VA and h VC/ VA [h may be ignored if PAO 2 and (Hb) are normal].
In the case of incomplete alveolar expansion in an otherwise normal lung, TL/VA or KCO increases linearly so that at FRC ($50% of VA at full inflation, i.e. TLC) KCO is > 150% of KCO at TLC (Stam et al., 1994; Hughes & Pride, 2001 . This KCO rise is caused mostly by an increase in the VC/ VA term (VC does not change and VA falls), while the DM/ VA ratio remains constant or falls slightly (Stam et al., 1991) . Clinically, a rise in KCO (up to 150% of that predicted for a normal TLC) will occur in neuromuscular, pleural or chest wall disease if TLC is reduced. Secondary factors, such as atelectasis or parenchymal disease, may limit the expected rise of KCO. An increase in pulmonary blood volume also increases KCO, because the VC/VA ratio rises (as does the DM/VA ratio). Apart from an increase in pulmonary venous pressure (as in mitral stenosis or congestive heart failure) (Puri et al., 1995) , the cause of the increase in VC is an increase in cardiac output. On exercise KCO (and TL,CO) increase by about 20% per 5 l min )1 increase in cardiac output from its resting value (Hsia et al., 1995) . At rest, pulmonary blood flow may increase as a result of left to right shunts, or blood flow may become more 'homogeneous', as in asthma (Collard et al., 1994) , representing an 'effective' blood flow increase. A much commoner situation in lung disease is where blood flow is diverted from diseased lung to normal lung, whose blood flow per unit volume increases. A clear-cut example is pneumonectomy, where blood flow per unit volume at rest doubles in the remaining lung, and KCO increases. Corris et al. (1987) , in a study of 28 patients before and after pneumonectomy, found that the post-pneumonectomy KCO was 110-131% predicted. Hughes & Pride (2001) have referred to this situation as loss of alveolar units (discrete) where discrete means that some normal (unaffected) lung units are present. There may be many causes (see Table 1 and Table 2 [II]). A low KCO will usually be associated with a low TL,CO, as it is unusual for VA to exceed its predicted normal value. A high KCO may be associated with a high, normal or a low TL,CO, depending (a) on the level of KCO, and (b) whether VA is normal or reduced. In alveolar haemorrhage, KCO is only elevated when active bleeding is taking place (Ewan et al., 1976) , but the Hb-corrected KCO may be sufficiently high to raise TL,CO, although VA may be somewhat reduced.
Causes of a low VA
There are two causes of a low VA; restrictive lung disease when absolute lung volumes are small (Table 2 ; I-III), but the VA/TLC ratio is normal, and obstructive lung disease (Table 2, IV) where TLC is usually normal or increased, but the sampled VA is <TLC due to incomplete mixing during breath holding. Restrictive lung disease can be subdivided further (see Table 2 ) into (I) lack of alveolar expansion, (II) loss of alveolar units, discrete, and (III) diffuse alveolar-capillary damage.
Causes of a low TL,CO
The same reduction in TL,CO (say to 60% predicted) can be produced by several combinations of KCO and VA. Hughes & Pride (2001) have shown that, in restrictive lung disease, a TL,CO of 60% predicted could be associated with (a) acute neuromuscular disease, (b) alveolar haemorrhage, (c) lung resection or collapse, (d) diffuse alveolar damage (connective tissue disease) or (e) pulmonary vascular pathology, depending on the precise combination of KCO and VA. Therefore, inspection of the components of TL,CO (KCO and VA) is essential if a reasonable interpretation of the TL,CO test is to be made. Table 3 lists examples of a low TL,CO in some pulmonary diseases. In inspiratory muscle weakness (Hart et al., 2002) , KCO is 130% predicted (for a normal TLC), but at this low VA (50% predicted) the KCO for a normal subject would be >150% predicted (Hughes & Pride, 2001) . As previously mentioned, parenchymal lung damage or atelectasis limit the rise in KCO in 'extrapulmonary' restriction.
Clinical examples
The KCO for a 50% reduction in VA due to loss of lung units is about 115% predicted (Hughes & Pride, 2001) , and this is what occurs post-pneumonectomy (Corris et al., 1987) . The situations in Table 3 where KCO is normal (sarcoidosis, bronchiectasis) but VA is reduced (and there is no airflow obstruction as a cause) are compatible with loss of lung units due to underlying disease with sparing of the remainder of the lung.
Where KCO is moderately impaired (84-85%) in CHF and fibrosing alveolitis, there is presumably a spectrum of lung damage -normal units with a KCO in the 100-110% range and diseased units with a low KCO (<80%). In Table 3 , note four situations (post-pneumonectomy, fibrosing alveolitis, primary PHT and emphysema) where TL,CO is essentially the same (54-58% predicted) but inspection of the VA and KCO patterns (and, in the case of emphysema, the FEV 1 /VC ratio) reveals different pathophysiological mechanisms in each case see Hughes (1999) for more examples.
TL,CO, exercise and arterial hypoxaemia
The TL,CO is rarely measured on exercise except in research protocols. In normal subjects, TL,CO increases in proportion to the workload; there is no evidence of a plateau (Hsia et al., 1995) . At near maximal exercise, TL,CO is 50% higher than resting values in men (25% higher in women) (Hsia et al., 1995) . In patients with lung disease, the fractional (percentage) increase in TL,CO for a given level of exercise is similar to that in normal subjects (reviewed in Hughes, 1991) , although exercise levels are quite low ( _ V VO 2 £ 1.0 L min )1 ). When resting TL,CO is <60% predicted, worsening of arterial hypoxaemia on exercise is seen almost invariably. Patients with interstitial lung disease and diffuse alveolar-capillary damage have been the subjects of most studies. It is not easy to differentiate diffusion limitation from _ V VA/ _ Q Q mismatch as causes of the exercise-induced hypoxaemia -a problem first studied in the 1940s (Baldwin et al., 1949) .
In interstitial lung disease patients with a low TL,CO, diffusion limitation, in terms of the contribution of the PA-Pc¢ (alveolar to end-capillary) gradient to the overall PA-Pa (alveolar to arterial) oxygen gradient, is about 10% at rest, 20-30% on light exercise and more than 50% at a _ V VO 2 of 1.0 L min )1 (Hughes, 1991) . The reason for the widening PA-Pc¢ gradient (failure of capillary PO 2 to equilibrate with alveolar PO 2 before red cells leave the alveolus) is a low diffusion-perfusion ratio ($TL,CO/ _ Q Q) within gas exchanging units, or for the lung overall if the disease process is diffuse. In interstitial lung disease, the TL/ _ Q Q ratio at rest is generally above the critical threshold for diffusion limitation, but on exercise, the increase in TL,CO, starting from a low base, is insufficient to match the increase in blood flow, so the TL/ _ Q Q ratio falls and a PA-Pc¢ gradient emerges. On the other hand, in patients with airflow obstruction (emphysema, for example), any change in PaO 2 on exercise will reflect ventilatory limitation and local _ V VA/ _ Q Q mismatching more than any decline in TL/ _ Q Q ratios.
Conclusion
Recent physiological evidence, using the Roughton-Forster analysis, and morphometric measurements on lungs postmortem, suggest that most of the resistance to CO transfer from alveolar gas to pulmonary capillary blood may lie in the red cell itself. The clinical implication is that TL,CO and KCO are focused primarily on the pulmonary capillary bed. Although nonspecific diffuse alveolar damage, as in interstitial fibrosis, or alveolar destruction, as in emphysema, will compromise the microvasculature and reduce TL,CO and KCO, pathology specific to the pulmonary circulation, without diffuse alveolar damage, such as vasculitis, raised pulmonary venous pressure or microvascular dilatation (as in PAVMs and HPS) also reduces TL,CO and KCO. Table 3 Typical values of a low TL,CO and its components (VA and KCO) in some common pulmonary conditions. % is percent of predicted normal value. As simple monitors of the integrity of the pulmonary microcirculation, TL,CO and KCO are uniquely valuable and important clinical tests.
